在ELSA-巴西研究中,分支链氨基酸与功能之间的关联
Viviane Calice-Silva1, Isabela M Bensenor2, Silvia M Titan2
1Pro-rim Foundation, Joinville, Brazil; School of Medicine, UNIVILLE, Joinville, Brazil; Center for Clinical and Epidemiologic Research, Hospital Universitario, University of São Paulo, Sao Paulo, Brazil.
Clinical nutrition (Edinburgh, Scotland)
|March 31, 2024
概括
高循环的分支链氨基酸 (BCAA) 与估计的膜过率 (eGFR) 呈现反向关联,与专蛋白-肌素比率 (ACR) 呈现积极关联. 需要进一步的研究来了解这些功能联系.
科学领域:
- 代谢健康 代谢健康
- 脏生理学 脏生理学
- 流行病学 流行病学
背景情况:
- 循环分支链氨基酸 (BCAA) 与代谢综合征的组成部分有关,如肥胖,葡萄糖受损,胰岛素抵抗,高血压和脂质失调.
- 关于功能与循环中的BCAA水平之间的关系的数据有限.
- 这项研究调查了巴西成年人BCAA水平和功能标志物之间的关联.
研究的目的:
- 为了检查循环分支链氨基酸 (BCAA) 和估计的淋巴细胞过率 (eGFR) 之间的关联.
- 调查循环中的BCAA与蛋白-肌素比率 (ACR),这是损伤的标志物之间的关联.
- 为了探索巴西成年人纵向研究 (ELSA-巴西) 队列中的这些关联.
主要方法:
- 从ELSA-巴西研究中分析了4912名参与者,使用核磁共振进行了基线BCAA测量 (氨酸,异氨酸,白氨酸).
- 使用CKD-EPI方程 (不包括种族) 和12h-专蛋白-肌素比率 (ACR) 评估估计的淋巴膜过率 (eGFR).
- 构建未调整和调整的多变量线性回归模型,以评估总和个体BCAA水平与eGFR和ACR之间的关系.
主要成果:
- 在参与者中,GFR<60毫升/分钟/1.73平方米和ACR≥30毫克/克的参与者中,BCAA水平较高.
- 在人口调整后观察到BCAA水平和eGFR之间的初始反向关联,但在进一步的混调整后,这种情况没有持续下去.
- 发现BCAA水平与ACR≥30 mg/g之间存在正相关性,在调整后也没有证实这一点.
结论:
- 循环分支链氨基酸 (BCAA) 与估计的淋巴细胞过率 (eGFR) 有相反的关联,与专蛋白-肌素比率 (ACR) 有积极的关联.
- 这些关联需要进一步调查,以阐明潜在的机制和临床影响.
- 这些发现突出了BCAA代谢和脏健康之间的潜在联系,需要进一步的研究.
相关概念视频
Factors Affecting Renal Clearance: Renal Impairment
91
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
91
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
217
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
217
Overview of Protein Metabolism
1.1K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.1K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
627
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
627


